Literature DB >> 24972675

Physiologic or pathologic hypertrophy: how can we know?

Emily J Lai1, Harry Rakowski.   

Abstract

Pathologic left ventricular hypertrophy due to hypertrophic cardiomyopathy is typically diagnosed based on compatible clinical and imaging findings. In a subset of patients however, the diagnosis is unclear, either due to the finding of concentric hypertrophy raising the possibility of physiologic hypertrophy due to athlete's heart or due to the potential of so-called hypertrophic cardiomyopathy 'phenocopies', which include Anderson-Fabry disease and cardiac amyloidosis. We review each of these diseases, highlighting important distinguishing features, the knowledge of which should permit the resolution of such diagnostic dilemmas.

Entities:  

Keywords:  Anderson-Fabry disease; athlete’s heart; cardiac amyloidosis; hypertrophic cardiomyopathy; left ventricular hypertrophy

Mesh:

Year:  2014        PMID: 24972675     DOI: 10.1586/14779072.2014.934226

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  1 in total

Review 1.  Narrative review of metabolomics in cardiovascular disease.

Authors:  Julian Müller; Thomas Bertsch; Justus Volke; Alexander Schmid; Rebecca Klingbeil; Yulian Metodiev; Bican Karaca; Seung-Hyun Kim; Simon Lindner; Tobias Schupp; Maximilian Kittel; Gernot Poschet; Ibrahim Akin; Michael Behnes
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 3.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.